With 2026 a bit more than half over, Berkshire Hathaway's B shares are down 1.8% year-to-date and 12.4 percentage points ...

The largest housing bill in decades has just become law after weeks of tense political standoff between President Trump and ...

Financial therapist Amanda Clayman has good advice for a way to curb your spending on holiday gifts this year while still ...

CNBC's Paulina Likos and Zev Fima discuss which Investing Club stocks could come out on top as investors scrutinize AI ...

There has been a period of so-called 'tokenmaxxing' at enterprises where companies would encourage employees to use as much AI as possible no matter the result. The tools often used were those from ...

Some states may have low costs and light regulation, but high crime and lack of healthcare are among important factors when ...

The two companies entered into a high-profile partnership in 2024 when ChatGPT was integrated into the iPhone's operating ...

CNBC's Paulina Likos and Zev Fima discuss Wall Street's shift from AI euphoria toward rationalization and what it means for investors.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

SK Hynix has soared to a trillion-dollar market cap by serving some of the biggest names in technology, including Nvidia and ...

That approach reflects a broader change in the market. Open-weight models, which can be downloaded, tuned and run by ...

The Financial Select Sector Index trades at roughly 15.5 times forward earnings — about a turn and a quarter cheaper than ...